Skip to content

Inspection Record

Jiangsu Hansoh Pharmaceutical Group Co Ltd. — FDA 483 Findings

US FDAInspected 2026-04-24Published 2026-10-22 6 findingsProcess validationAseptic processing and sterility assuranceDeviation, CAPA, and investigationEquipment and facility

Inspectors Sandra A Boyd · Karen A BriggsThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Process validation

Control procedures are not established that describe in process controls which validate the performance ofthose manufacturing processes that may be responsible for causing variably in the characteristics of in-process materials and the drug product.

2Aseptic processing and sterility assurance

Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established.

3Deviation, CAPA, and investigation

Your firm failed to thoroughly investigate any unexplained discrepancy or failure ofa batch or any of its components to meet any of its specifications whether or not the batch has already been distributed.

4Equipment and facility

Routine calibration, inspection, checking ofautomatic, mechanical, electronic equipment is not performed according to a written program designed to assure proper performance.

5Aseptic processing and sterility assurance

Aseptic processing areas -ate deficient regarding the system for monitoring environmental conditions.

6Aseptic processing and sterility assurance

Your firm failed to establish an adequate system for cleaning and disinfecting the room and equipment to produce aseptic conditions.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-10-22. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Jiangsu Hansoh Pharmaceutical Group Co Ltd. company profile — full historyAll US FDA findings US FDA documents, 2026 Go to Findings search
Linked from (backlinks)
Briefs that featured this document
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.